193 related articles for article (PubMed ID: 37869587)
21. Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy.
Wang Y; Peng B; Ning C; He S; Yang H; Mao Y; Sun L
Front Immunol; 2022; 13():966167. PubMed ID: 36304466
[TBL] [Abstract][Full Text] [Related]
22. Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9764203. PubMed ID: 38094457
[TBL] [Abstract][Full Text] [Related]
23. Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9764352. PubMed ID: 37860436
[TBL] [Abstract][Full Text] [Related]
24. Retracted: Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9815950. PubMed ID: 38230074
[TBL] [Abstract][Full Text] [Related]
25. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
[TBL] [Abstract][Full Text] [Related]
26. Retracted: Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9831949. PubMed ID: 37388014
[TBL] [Abstract][Full Text] [Related]
27. Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9754067. PubMed ID: 37501844
[TBL] [Abstract][Full Text] [Related]
28. Retracted: Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.
International BR
Biomed Res Int; 2024; 2024():9784513. PubMed ID: 38230025
[TBL] [Abstract][Full Text] [Related]
29. Retracted: Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9818549. PubMed ID: 38077877
[TBL] [Abstract][Full Text] [Related]
30. Predicting Prognosis of Hepatocellular Carcinoma Patients Based on the Expression Signatures of Mitophagy Genes.
Li YK; Yan LR; Jiang LY; Xu Q; Wang BG
Dis Markers; 2022; 2022():4835826. PubMed ID: 36157211
[TBL] [Abstract][Full Text] [Related]
31. Retracted: Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2023; 2023():9841321. PubMed ID: 38075334
[TBL] [Abstract][Full Text] [Related]
32. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
[TBL] [Abstract][Full Text] [Related]
33. Retracted: Analysing a Novel RNA-Binding-Protein-Related Prognostic Signature Highly Expressed in Breast Cancer.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9792854. PubMed ID: 37829426
[TBL] [Abstract][Full Text] [Related]
34. Retracted: Identification of Ferroptosis-Related Long Noncoding RNA and Construction of a Novel Prognostic Signature for Gastric Cancer.
Markers D
Dis Markers; 2023; 2023():9810178. PubMed ID: 37387742
[TBL] [Abstract][Full Text] [Related]
35. Retracted: Identifying a 6-Gene Prognostic Signature for Lung Adenocarcinoma Based on Copy Number Variation and Gene Expression Data.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9890283. PubMed ID: 38189008
[TBL] [Abstract][Full Text] [Related]
36. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
37. Retracted: Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9808126. PubMed ID: 38550199
[TBL] [Abstract][Full Text] [Related]
38. Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma.
Zhuge L; Huang B; Xie J; Gao Z; Zheng D; Zheng S; Xiang J; Zhang J
Cancer Manag Res; 2020; 12():12885-12894. PubMed ID: 33364836
[TBL] [Abstract][Full Text] [Related]
39. Retracted: Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma.
International BR
Biomed Res Int; 2024; 2024():9817540. PubMed ID: 38550120
[TBL] [Abstract][Full Text] [Related]
40. Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9760920. PubMed ID: 38094413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
